RecruitingNCT05098769

A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.

A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using Parameters Obtained by Computed Tomographic Pulmonary Angiography.

Sponsor

Shengjing Hospital

Enrollment

300 participants

Start Date

Jan 18, 2021

Study Type

OBSERVATIONAL

Conditions

Pulmonary Embolism and Thrombosis Deterioration, Clinical

Summary

This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing a new scoring tool to predict which patients with acute pulmonary embolism (PE) — a blood clot in the lungs — are at highest risk for serious complications or death. Researchers will use information from CT pulmonary angiography (CTPA) scans, heart ultrasound (echocardiography), and blood tests to build and validate this prediction model. You may be eligible if: - You are 18 years of age or older - You have been diagnosed with a pulmonary embolism confirmed by CT pulmonary angiography (CTPA) You may NOT be eligible if: - You are pregnant - You received clot-dissolving (reperfusion/thrombolytic) treatment before hospital admission - Key data is missing from your CT scan, echocardiogram, or blood test results (troponin I, NT-pro BNP) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.